China Medicine's Letter to Shareholders and Business Update -
China Medicine Announces Strong Second Quarter 2008 Results -
China Medicine Announces Conference Call to Discuss Second Quarter 2008 Results -
China In-Focus: China Medicine Retains Australian Patent -
China Medicine granted new Australian patent -
China Medicine Corporation Obtains Australian Patent for rADTZ -
China Medicine Releases White Paper on Developing Recombinant Aflatoxin-Detoxifizyme -
China Medicine maintains rights to sell 2,300 drugs -
China Medicine Maintains Exclusive Rights to Distribute 2,300 Pharmaceutical Products -
China Medicine Corporation Held Annual General Meeting of Shareholders -
China Medicine Industry Jan-Feb Sales Revenue Up 32.02% -
China Medicine Announces Solid First Quarter 2008 Results -
China Medicine Announces Conference Call to Discuss First Quarter 2008 Results -
China Medicine & Health Products to Grow by 20% in 08 -
CHME: To Present At Brean Murray, Carret China Conference @ 21:45 ET [delayed] -
The Maybach Financial Group: China Medicine Corp. Review in Progress -
China Medicine Announces Record Fourth Quarter and Fiscal Year 2007 Results -
China Medicine Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results -
China Medicine Signs With CCG Elite -
Page 1 of 1
1 Previous | Next
|